Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin 4 pseudogene 1 (PRDX4P1) is a processed pseudogene related to the peroxiredoxin 4 (PRDX4) gene in Homo sapiens. Unlike its parent gene PRDX4, which encodes an active peroxiredoxin antioxidant enzyme, PRDX4P1 does not code for a functional protein and has no known molecular function or involvement in disease pathways. There are no reports of therapeutic targeting, clinical relevance, or drug interaction for this pseudogene. PRDX4P1 is categorized as a pseudogene, not a protein-coding gene, and thus does not produce an active protein product or participate in biochemical pathways the way active therapeutic targets do. There is no evidence of involvement in known biological functions, disease associations, or therapeutic mechanisms. None of the disease or drug interaction information available for the parent gene PRDX4 is applicable to PRDX4P1; the two should be carefully distinguished. PRDX4P1 is sometimes detected in gene expression data, but this represents transcriptional noise or residual expression, not a functional role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin 4 pseudogene 1 (PRDX4P1).